Clinical outcomes after use of checkpoint inhibitor immunotherapies in people with multiple sclerosis.

Published in: Multiple sclerosis journal - experimental, translational and clinical (2024)

In this cohort, no people with MS experienced clinical relapses and one-third experienced asymptomatic radiological activity following ICI treatment.

Keyphrases